Hemocue is a global leader in point-of-care diagnostics, developing, producing and marketing medical diagnostic products for healthcare providers around the world. Their product portfolio includes point-of-care systems for hemoglobin, glucose and urine albumin testing.
- The company was founded in 1982 by Sture Ericson in Angelholm, Sweden.
- Hemocue was acquired by Quest Diagnostics in 2007.
- In 2013, Radiometer, a Danish company, acquired Hemocue from Quest Diagnostics, and Hemocue became a stand-alone operating company within the Radiometer group.
Abbott Laboratories is a global healthcare company that develops and manufactures pharmaceuticals, medical devices, diagnostics, and nutrition products. They offer point-of-care testing for diabetes, cholesterol, and other conditions.
Roche Diagnostics is a global healthcare company that develops and manufactures diagnostic tests and systems for laboratories, clinics and hospitals. They provide point-of-care testing for blood gases, electrolytes, and other analytes.
Siemens Healthineers is a global medical technology company that develops, manufactures, and sells diagnostic imaging and laboratory diagnostics equipment and software. They offer point-of-care testing for glucose, hemoglobin, and other parameters.
Indicates the hemoglobin level in blood samples for anemia screening and monitoring.
Determines blood glucose for diabetes screening and management.
Indicates the presence of albumin in urine samples for the screening and diagnosis of kidney disease.
Hemocue is a global leader in point-of-care diagnostics, developing, producing and marketing medical diagnostic products for healthcare providers around the world.
Hemocue offers point-of-care systems for hemoglobin, glucose and urine albumin testing.
The main competitors of Hemocue include Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers.
Hemocue is based in Angelholm, Sweden.
Hemocue was founded in 1982 by Sture Ericson in Angelholm, Sweden. It was later acquired by Quest Diagnostics in 2007, and then by Radiometer in 2013.